Home

Elucida Research is a privately-held biotechnology company that has provided research expertise to universities and the life sciences community since 2000. Dr. Preston Mason (President and co-founder) and his colleagues have published over 500 scientific articles, reviews and abstracts related to their biomedical research. They also hold a number of patents and are frequently requested to speak at national and international scientific meetings. The primary purpose of the company is to alleviate human suffering by applying innovative approaches in nanotechnology and biochemistry to the study and treatment of disease. The research is especially focused on cardiovascular disease, including the role(s) that inflammation and oxidative stress have in its etiology.

The innovative work of Elucida Research has been featured on Frontline, the New York Times, the Wall Street Journal and numerous other media outlets. The staff have academic appointments with Brigham and Women’s Hospital, an affiliate of Harvard Medical School, and the University of New Hampshire graduate school.

Elucida Research is located in Beverly, Massachusetts, USA.